Insider Transactions of Kiniksa Pharmaceuticals International, plc

Sanj K Patel, Chairman & CEO of Kiniksa Pharmaceuticals International, plc, reported several transactions on April 6-7, 2026. Patel acquired 7,278 Class A Ordinary Shares at $10.36 per share and subsequently sold the same number of shares at a weighted average price of $50.01, as part of a 10b5-1 plan. Additionally, Patel acquired 9,991 Restricted Share Units (RSUs) with a $\$0$ transaction price, which vest over four years. Following these transactions, Patel directly holds 0 Class A Ordinary Shares. Indirectly, shares are held through The Marina 2016 Irrevocable Trust (109,795 shares) and The Anglia 2013 Revocable Trust (51,794 shares). Patel also disposed of 4,831 shares indirectly held, with a transaction price of $48.94. The filing also notes the exercise of a vested stock option for 7,278 shares, which were disposed of, and the acquisition of 9,991 RSUs.